BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51:92-99. [PMID: 14872461 DOI: 10.1002/art.20077] [Cited by in Crossref: 329] [Cited by in F6Publishing: 228] [Article Influence: 19.4] [Reference Citation Analysis]
Number Citing Articles
1 Gago R, Shum LM, Vilá LM. Right upper quadrant abdominal pain as the initial presentation of polyarteritis nodosa. BMJ Case Rep 2017;2017:bcr2016218019. [PMID: 28228431 DOI: 10.1136/bcr-2016-218019] [Reference Citation Analysis]
2 Faverio P, Bonaiti G, Bini F, Vaghi A, Pesci A. Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy. Ther Clin Risk Manag 2018;14:2385-96. [PMID: 30573961 DOI: 10.2147/TCRM.S159949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 6.7] [Reference Citation Analysis]
3 Abousy M, Byrd A, Succaria F, Kerns M, Caffrey J. Burn Center Management of Severe Necrotic Cutaneous Polyarteritis Nodosa in a Patient With a History of Thymoma. Cureus 2021;13:e13134. [PMID: 33728150 DOI: 10.7759/cureus.13134] [Reference Citation Analysis]
4 Vinit J, Muller G, Bielefeld P, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF. Churg-Strauss syndrome: retrospective study in Burgundian population in France in past 10 years. Rheumatol Int 2011;31:587-93. [PMID: 20039171 DOI: 10.1007/s00296-009-1275-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
5 Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12:570-579. [PMID: 27464484 DOI: 10.1038/nrrheum.2016.123] [Cited by in Crossref: 125] [Cited by in F6Publishing: 102] [Article Influence: 25.0] [Reference Citation Analysis]
6 Scott J, Hartnett J, Mockler D, Little MA. Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review. Autoimmun Rev 2020;19:102660. [PMID: 32947040 DOI: 10.1016/j.autrev.2020.102660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Meeuwissen J, Maertens J, Verbeken E, Blockmans D. Case reports: testicular pain as a manifestation of polyarteritis nodosa. Clin Rheumatol. 2008;27:1463-1466. [PMID: 18651100 DOI: 10.1007/s10067-008-0970-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
8 Pamuk ÖN, Dönmez S, Calayır GB, Pamuk GE. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol 2016;35:2063-71. [DOI: 10.1007/s10067-016-3232-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
9 Chaigne B, Dion J, Guillevin L, Mouthon L, Terrier B. Physiopathologie de la granulomatose éosinophilique avec polyangéite (Churg-Strauss). La Revue de Médecine Interne 2016;37:337-42. [DOI: 10.1016/j.revmed.2015.10.339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Gendelman S, Zeft A, Spalding SJ. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol 2013;40:929-35. [PMID: 23637321 DOI: 10.3899/jrheum.120808] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
11 Laroia ST, Lata S. Hypertension in the liver clinic - polyarteritis nodosa in a patient with hepatitis B. World J Clin Cases 2016; 4(3): 94-98 [PMID: 26989675 DOI: 10.12998/wjcc.v4.i3.94] [Reference Citation Analysis]
12 Knight A, Sandin S, Askling J. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum 2008;58:302-7. [PMID: 18163522 DOI: 10.1002/art.23157] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
13 Khosla A, Andring B, Atchie B, Zerr J, White B, Macfarlane J, Kalva SP. Systemic Vasculopathies. Radiologic Clinics of North America 2016;54:613-28. [DOI: 10.1016/j.rcl.2015.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Almaani S, Fussner LA, Brodsky S, Meara AS, Jayne D. ANCA-Associated Vasculitis: An Update. J Clin Med 2021;10:1446. [PMID: 33916214 DOI: 10.3390/jcm10071446] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Samarkos M, Loizou S, Vaiopoulos G, Davies KA. The Clinical Spectrum of Primary Renal Vasculitis. Seminars in Arthritis and Rheumatism 2005;35:95-111. [DOI: 10.1016/j.semarthrit.2005.05.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
16 Pecoraro A, Crescenzi L, Carucci L, Genovese A, Spadaro G. Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA). Int Immunopharmacol 2017;45:13-5. [PMID: 28152445 DOI: 10.1016/j.intimp.2017.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Dziuban EJ, Castle VP, Haftel HM. Microscopic polyangiitis in an adolescent presenting as severe anemia and syncope. Rheumatol Int 2011;31:1507-10. [PMID: 20013269 DOI: 10.1007/s00296-009-1270-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Martin de Frémont G, Gimenez de Mestral S, Jubault V, Chauchard M, Mekinian A, Fain O. [Polyarteritis nodosa, an alternative diagnosis of giant cell arteritis in cases of temporal arteritis]. Rev Med Interne 2019;40:533-5. [PMID: 31201015 DOI: 10.1016/j.revmed.2019.05.012] [Reference Citation Analysis]
19 Venturini M, Orsi M, Colombo M, Querques G, Agostini G, Bozzolo E, Del Maschio A. Drug-eluting stent patency at 6 months in the pedal artery of a patient with polyarteritis nodosa: a case report. J Vasc Interv Radiol 2013;24:907-10. [PMID: 23707099 DOI: 10.1016/j.jvir.2013.02.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A, Luberto F, Pipitone N, Salvarani C. Epidemiology of granulomatosis with polyangiitis (Wegener׳s granulomatosis) in Northern Italy: A 15-year population-based study. Seminars in Arthritis and Rheumatism 2014;44:202-7. [DOI: 10.1016/j.semarthrit.2014.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
21 Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy. 2013;68:261-273. [PMID: 23330816 DOI: 10.1111/all.12088] [Cited by in Crossref: 127] [Cited by in F6Publishing: 96] [Article Influence: 15.9] [Reference Citation Analysis]
22 Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford) 2020;59:iii84-94. [PMID: 32348510 DOI: 10.1093/rheumatology/kez570] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
23 Wu EY, Hernandez ML, Jennette JC, Falk RJ. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review. J Allergy Clin Immunol Pract 2018;6:1496-504. [PMID: 30197069 DOI: 10.1016/j.jaip.2018.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
24 Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry M, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DRW. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss). Ann Rheum Dis 2016;75:396-401. [DOI: 10.1136/annrheumdis-2014-206095] [Cited by in Crossref: 115] [Cited by in F6Publishing: 95] [Article Influence: 16.4] [Reference Citation Analysis]
25 Jagwani AV, Fathi NQ, Jailani RF, Zakaria AD. Rare and unusual case of polyarteritis nodosa involving the gastrointestinal tract leading to bowel gangrene. BMJ Case Rep 2017;2017:bcr2016217865. [PMID: 28062430 DOI: 10.1136/bcr-2016-217865] [Reference Citation Analysis]
26 Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010;22:21-8. [PMID: 19851111 DOI: 10.1097/BOR.0b013e328333390b] [Cited by in Crossref: 66] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
27 Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, Ronco P, Rondeau E, Fain O. Renal Granulomatoses: A Retrospective Study of 40 Cases and Review of the Literature. Medicine 2007;86:170-80. [DOI: 10.1097/md.0b013e3180699f55] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
28 Zampieri M, Emmi G, Beltrami M, Fumagalli C, Urban ML, Dei LL, Marchi A, Berteotti M, Tomberli A, Baldini K, Bettiol A, Pradella S, Silvestri E, Marchionni N, Vaglio A, Olivotto I, Prisco D. Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre. Eur J Intern Med 2021;85:68-79. [PMID: 33358337 DOI: 10.1016/j.ejim.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Plumb LA, Oni L, Marks SD, Tullus K. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management. Pediatr Nephrol. 2018;33:25-39. [PMID: 28062909 DOI: 10.1007/s00467-016-3559-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
30 Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P;  French Vasculitis Study Group. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore). 2005;84:313-322. [PMID: 16148731 DOI: 10.1097/01.md.0000180792.80212.5e] [Cited by in Crossref: 283] [Cited by in F6Publishing: 159] [Article Influence: 17.7] [Reference Citation Analysis]
31 Cartin-ceba R, Peikert T, Specks U. Pathogenesis of ANCA-Associated Vasculitis. Curr Rheumatol Rep 2012;14:481-93. [DOI: 10.1007/s11926-012-0286-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
32 Wang Z, Han L, Yu L. Effects of surgery and topical medication on eosinophilic granulomatosis with polyangiitis with otitis media and sinusitis: a case report. J Int Med Res 2020;48:300060520920049. [PMID: 32345078 DOI: 10.1177/0300060520920049] [Reference Citation Analysis]
33 Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun 2014;48-49:99-103. [PMID: 24530234 DOI: 10.1016/j.jaut.2014.01.018] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 13.3] [Reference Citation Analysis]
34 Binda V, Moroni G, Messa P. ANCA-associated vasculitis with renal involvement. J Nephrol. 2018;31:197-208. [PMID: 28560688 DOI: 10.1007/s40620-017-0412-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
35 Colmegna I, Maldonado-Cocco JA. Polyarteritis nodosa revisited. Curr Rheumatol Rep. 2005;7:288-296. [PMID: 16045832 DOI: 10.1007/s11926-005-0039-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
36 Treppo E, Binutti M, Agarinis R, De Vita S, Quartuccio L. Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives. J Clin Med 2021;10:3773. [PMID: 34501224 DOI: 10.3390/jcm10173773] [Reference Citation Analysis]
37 Gatenby PA. Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture?: AASV: nature or nurture. Internal Medicine Journal 2012;42:351-9. [DOI: 10.1111/j.1445-5994.2011.02705.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 van Hest NA, Grant AD, Smit F, Story A, Richardus JH. Estimating infectious diseases incidence: validity of capture-recapture analysis and truncated models for incomplete count data. Epidemiol Infect 2008;136:14-22. [PMID: 17352840 DOI: 10.1017/S0950268807008254] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014;13:1121-1125. [PMID: 25149391 DOI: 10.1016/j.autrev.2014.08.017] [Cited by in Crossref: 123] [Cited by in F6Publishing: 99] [Article Influence: 17.6] [Reference Citation Analysis]
40 Pagnoux C, Kluger N, Francès C, Guillevin L. Cutaneous granulomatous vasculitis and extravascular granulomas. Expert Review of Dermatology 2014;1:315-26. [DOI: 10.1586/17469872.1.2.315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K. Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun 2006;7:81-4. [DOI: 10.1038/sj.gene.6364262] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
42 Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am 2010;36:527-43. [PMID: 20688248 DOI: 10.1016/j.rdc.2010.05.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
43 Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 2021;73:1366-83. [PMID: 34235894 DOI: 10.1002/art.41773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 de Azevedo FVA, Lima FO, de Carvalho JF, de Saboia Mont'Alverne AR, Rodrigues CEM. Granulomatosis with polyangiitis in Northeastern Brazil: study of 25 cases and review of the literature. Adv Rheumatol 2018;58:10. [PMID: 30657074 DOI: 10.1186/s42358-018-0010-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Balcı-peynircioğlu B, Kaya-akça Ü, Arıcı ZS, Avcı E, Akkaya-ulum ZY, Karadağ Ö, Kalyoncu U, Bilginer Y, Yılmaz E, Özen S. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology 2020;59:1372-80. [DOI: 10.1093/rheumatology/kez410] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
46 Semple D, Keogh J, Forni L, Venn R. Clinical review: Vasculitis on the intensive care unit--part 1: diagnosis. Crit Care 2005;9:92-7. [PMID: 15693990 DOI: 10.1186/cc2936] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
47 Groh M, Pagnoux C, Guillevin L. Eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): where are we now? Eur Respir J 2015;46:1255-8. [PMID: 26521277 DOI: 10.1183/13993003.00963-2015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
48 Vong S, Goyet S, Ly S, Ngan C, Huy R, Duong V, Wichmann O, Letson GW, Margolis HS, Buchy P. Under-recognition and reporting of dengue in Cambodia: a capture–recapture analysis of the National Dengue Surveillance System. Epidemiol Infect 2012;140:491-9. [DOI: 10.1017/s0950268811001191] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
49 Pettigrew HD, Teuber SS, Gershwin ME. Polyarteritis Nodosa. Compr Ther 2007;33:144-9. [DOI: 10.1007/s12019-007-0012-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
50 Xiao H, Hu P, Falk RJ, Jennette JC. Overview of the Pathogenesis of ANCA-Associated Vasculitis. Kidney Dis (Basel) 2016;1:205-15. [PMID: 27536680 DOI: 10.1159/000442323] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
51 Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583-1594. [PMID: 27338776 DOI: 10.1136/annrheumdis-2016-209133] [Cited by in Crossref: 497] [Cited by in F6Publishing: 373] [Article Influence: 99.4] [Reference Citation Analysis]
52 Sada K, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H; for the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour, Welfare of Japan. A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Modern Rheumatology 2014;24:640-4. [DOI: 10.3109/14397595.2013.857582] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
53 Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken) 2021;73:1088-105. [PMID: 34235880 DOI: 10.1002/acr.24634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Saadoun D, Vautier M, Cacoub P. Medium- and Large-Vessel Vasculitis. Circulation 2021;143:267-82. [PMID: 33464968 DOI: 10.1161/CIRCULATIONAHA.120.046657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
55 Groh M, Masciocco G, Kirchner E, Kristen A, Pellegrini C, Varnous S, Bortman G, Rosenberg M, Brucato A, Waterworth P, Bonacina E, Facchetti F, Calabrese L, Gregorini G, Scali JJ, Starling R, Frigerio M, D'Armini AM, Guillevin L. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Heart Lung Transplant 2014;33:842-50. [PMID: 24709271 DOI: 10.1016/j.healun.2014.02.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
56 Leyens J, Bender TTA, Mücke M, Stieber C, Kravchenko D, Dernbach C, Seidel MF. The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis. Orphanet J Rare Dis 2021;16:326. [PMID: 34294115 DOI: 10.1186/s13023-021-01945-8] [Reference Citation Analysis]
57 Vaglio A, Casazza I, Grasselli C, Corradi D, Sinico RA, Buzio C. Churg-Strauss syndrome. Kidney Int 2009;76:1006-11. [PMID: 19516244 DOI: 10.1038/ki.2009.210] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
58 Yazici H, Seyahi E, Yurdakul S. Behçet's syndrome is not so rare: why do we need to know? Arthritis Rheum 2008;58:3640-3. [PMID: 19035470 DOI: 10.1002/art.24146] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
59 Pagnoux C, Mendel A. Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations. Expert Review of Clinical Immunology 2019;15:939-49. [DOI: 10.1080/1744666x.2019.1656527] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Berti A, Dejaco C. Update on the epidemiology, risk factors, and outcomes of systemic vasculitides. Best Practice & Research Clinical Rheumatology 2018;32:271-94. [DOI: 10.1016/j.berh.2018.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
61 Watts RA, Scott DG. L32. ANCA vasculitis over the world. What do we learn from country differences? Presse Med 2013;42:591-3. [PMID: 23481365 DOI: 10.1016/j.lpm.2013.01.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
62 Alfaro TM, Duarte C, Monteiro R, Simão A, Calretas S, Nascimento Costa JM. Churg-Strauss syndrome: case series. Rev Port Pneumol 2012;18:86-92. [PMID: 22240164 DOI: 10.1016/j.rppneu.2011.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
63 Mastalerz L, Celińska-Lӧwenhoff M, Krawiec P, Batko B, Tłustochowicz W, Undas A. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia. PLoS One 2015;10:e0142167. [PMID: 26540111 DOI: 10.1371/journal.pone.0142167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
64 Hernández-rodríguez J, Cid MC. Polyarteritis Nodosa. In: Shoenfeld Y, Cervera R, Gershwin ME, editors. Diagnostic Criteria in Autoimmune Diseases. Totowa: Humana Press; 2008. pp. 87-92. [DOI: 10.1007/978-1-60327-285-8_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
65 Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int 2019;68:430-6. [PMID: 31266709 DOI: 10.1016/j.alit.2019.06.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
66 Ennis D, Lee JK, Pagnoux C. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. Expert Opin Biol Ther 2019;19:617-30. [PMID: 31146595 DOI: 10.1080/14712598.2019.1623875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
67 Knight A, Sandin S, Askling J. Increased Risk of Autoimmune Disease in Families with Wegener’s Granulomatosis. J Rheumatol 2010;37:2553-8. [DOI: 10.3899/jrheum.091280] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
68 Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M. Churg-Strauss syndrome. Autoimmun Rev 2015;14:341-8. [PMID: 25500434 DOI: 10.1016/j.autrev.2014.12.004] [Cited by in Crossref: 152] [Cited by in F6Publishing: 113] [Article Influence: 21.7] [Reference Citation Analysis]
69 Gilyarov MY, Belikova LP, Shchukin IA, Fidler MS, Avakyan GG, Shustrova GE, Martynov MY, Svet AV. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:93-102. [PMID: 28635862 DOI: 10.17116/jnevro201611610193-102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Abril A. Churg-strauss syndrome: an update. Curr Rheumatol Rep 2011;13:489-95. [PMID: 21863326 DOI: 10.1007/s11926-011-0205-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
71 Rodrigo D, Perera R, de Silva J. Classic polyarteritis nodosa associated with hepatitis C virus infection: a case report. J Med Case Rep. 2012;6:305. [PMID: 22979958 DOI: 10.1186/1752-1947-6-305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 Moroni G, Ponticelli C. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmunity Reviews 2014;13:723-9. [DOI: 10.1016/j.autrev.2014.02.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
73 Ntatsaki E, Watts RA, Scott DG. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36:447-461. [PMID: 20688243 DOI: 10.1016/j.rdc.2010.04.002] [Cited by in Crossref: 138] [Cited by in F6Publishing: 84] [Article Influence: 12.5] [Reference Citation Analysis]
74 Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009;61:1121-1129. [PMID: 19644909 DOI: 10.1002/art.24695] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
75 Karadag O, Erden A, Bilginer Y, Gopaluni S, Sari A, Armagan B, Ertenli I, Ozen S, Jayne D. A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts. Rheumatol Int 2018;38:1833-40. [DOI: 10.1007/s00296-018-4122-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
76 Chugg K, Aiyappan V, Bowden J. A 67-year-old woman with asthma, word finding difficulty, and an abnormal chest radiograph. Chest 2013;143:862-5. [PMID: 23460166 DOI: 10.1378/chest.12-1130] [Reference Citation Analysis]
77 Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT. Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014. Semin Arthritis Rheum. 2020;50:66-70. [PMID: 31362895 DOI: 10.1016/j.semarthrit.2019.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Genga E, Oyoo O, Adebajo A. Vasculitis in Africa. Curr Rheumatol Rep 2018;20:4. [PMID: 29464351 DOI: 10.1007/s11926-018-0711-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
79 Ullah S, Ali M, Kyaw P, Nayeemuddin F, Sreedhar R, Gao J. P-ANCA negative eosinophilic granulomatosis with polyangiitis. Respir Med Case Rep 2019;27:100830. [PMID: 30989049 DOI: 10.1016/j.rmcr.2019.100830] [Reference Citation Analysis]
80 Kaneko T, Hino S, Iijima Y, Horie N. Microscopic Polyangiitis Initially Presumed to Be Endocarditis. Case Rep Dent 2020;2020:7020595. [PMID: 32257454 DOI: 10.1155/2020/7020595] [Reference Citation Analysis]
81 Beule A. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Curr Top Otorhinolaryngol Head Neck Surg 2015;14:Doc11. [PMID: 26770285 DOI: 10.3205/cto000126] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
82 Sharma A, Dogra S, Sharma K. Granulomatous Vasculitis. Dermatol Clin 2015;33:475-87. [PMID: 26143427 DOI: 10.1016/j.det.2015.03.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
83 Pearce FA, Lanyon PC, Grainge MJ, Shaunak R, Mahr A, Hubbard RB, Watts RA. Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population. Rheumatology (Oxford) 2016;55:1656-63. [PMID: 27274096 DOI: 10.1093/rheumatology/kew232] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
84 Terrier B, Darbon R, Durel CA, Hachulla E, Karras A, Maillard H, Papo T, Puechal X, Pugnet G, Quemeneur T, Samson M, Taille C, Guillevin L; Collaborators. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Orphanet J Rare Dis 2020;15:351. [PMID: 33372616 DOI: 10.1186/s13023-020-01621-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
85 Lin YC, Kalot MA, Husainat NM, Byram K, Dua AB, James KE, Springer JM, Turgunbaev M, Villa-Forte A, Abril A, Langford C, Maz M, Chung SA, Mustafa RA. Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments. ACR Open Rheumatol 2021;3:91-100. [PMID: 33512781 DOI: 10.1002/acr2.11189] [Reference Citation Analysis]
86 Chen Y, Ding Y, Liu Z, Zhang H, Liu Z, Hu W. Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients. BMC Nephrol 2016;17:101. [PMID: 27461086 DOI: 10.1186/s12882-016-0319-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 O'Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 2007;37:242-6. [PMID: 17388864 DOI: 10.1111/j.1445-5994.2006.01297.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
88 Soowamber M, Weizman AV, Pagnoux C. Gastrointestinal aspects of vasculitides. Nat Rev Gastroenterol Hepatol 2017;14:185-94. [PMID: 27876769 DOI: 10.1038/nrgastro.2016.179] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
89 Menzella F, Galeone C, Ghidoni G, Ruggiero P, Capobelli S, Simonazzi A, Catellani C, Scelfo C, Livrieri F, Facciolongo N. Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab. Multidiscip Respir Med 2021;16:779. [PMID: 34221399 DOI: 10.4081/mrm.2021.779] [Reference Citation Analysis]
90 Chung SA, Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am. 2010;36:545-558. [PMID: 20688249 DOI: 10.1016/j.rdc.2010.04.003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
91 Noble J, Jouve T, Malvezzi P, Rostaing L. Renal complications of liver diseases. Expert Review of Gastroenterology & Hepatology 2018;12:1135-42. [DOI: 10.1080/17474124.2018.1530984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
92 Guilpain P, Chanseaud Y, Tamby M, Mahr A, Servettaz A, Guillevin L, Mouthon L. Pathogénie des vascularites systémiques primitives (I) : vascularites ANCA-positives. La Presse Médicale 2005;34:1013-22. [DOI: 10.1016/s0755-4982(05)84104-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
93 Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012;11:754-65. [PMID: 22387972 DOI: 10.1016/j.autrev.2012.02.001] [Cited by in Crossref: 213] [Cited by in F6Publishing: 199] [Article Influence: 23.7] [Reference Citation Analysis]
94 Allende DS, Booth CN. Wegener's granulomatosis of the breast: a rare entity with daily clinical relevance. Annals of Diagnostic Pathology 2009;13:351-7. [DOI: 10.1016/j.anndiagpath.2009.04.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
95 Khalil HH, Marsden J, Akbar N, Gordon P, Roberts J, Schulte KM. Polyarteritis nodosa of the breast: presentation and management. Int J Surg 2009;7:446-50. [PMID: 19540945 DOI: 10.1016/j.ijsu.2009.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
96 Schirmer JH, Moosig F. [Update: polyarteritis nodosa]. Z Rheumatol 2018;77:397-408. [PMID: 29808333 DOI: 10.1007/s00393-018-0469-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
97 Greco A, De Virgilio A, Rizzo MI, Gallo A, Magliulo G, Fusconi M, Ruoppolo G, Tombolini M, Turchetta R, de Vincentiis M. Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches. Autoimmun Rev 2015;14:837-44. [PMID: 25992801 DOI: 10.1016/j.autrev.2015.05.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
98 Xiao H. L9. The role of genetic background in an animal model of ANCA-associated vasculitis. Presse Med 2013;42:517-20. [PMID: 23465298 DOI: 10.1016/j.lpm.2013.01.009] [Reference Citation Analysis]
99 Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G, Kostic M, Markovic-Lipkovski J, Nikolic M, Spasojevic B. Childhood microscopic polyangiitis associated with MPO-ANCA. Pediatr Nephrol 2006;21:46-53. [PMID: 16252100 DOI: 10.1007/s00467-005-2063-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
100 Wilke L, Prince-Fiocco M, Fiocco GP. Microscopic polyangiitis: a large single-center series. J Clin Rheumatol 2014;20:179-82. [PMID: 24847742 DOI: 10.1097/RHU.0000000000000108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Biscay P, Ralazamahaleo M, Lazaro E, Richez C, Seneschal J, Rigothier C, Contin-bordes C, Duffau P. Évaluation de la pertinence des demandes d’anticorps anticytoplasme des polynucléaires neutrophiles : étude rétrospective menée au sein du centre hospitalier universitaire de Bordeaux. La Revue de Médecine Interne 2017;38:656-62. [DOI: 10.1016/j.revmed.2017.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Izquierdo-domínguez A, Cordero Castillo A, Alobid I, Mullol J. Churg-Strauss Syndrome or Eosinophilic Granulomatosis with Polyangiitis. Sinusitis 2016;1:24-43. [DOI: 10.3390/sinusitis1010024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Yurdakul S, Yazıcı Y. Epidemiology of Behçet’s Syndrome and Regional Differences in Disease Expression. In: Yazıcı Y, Yazıcı H, editors. Behçet’s Syndrome. New York: Springer; 2010. pp. 35-52. [DOI: 10.1007/978-1-4419-5641-5_3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
104 Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L. Population-based prevalence study of Behçet‘s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58:3951-3959. [PMID: 19035493 DOI: 10.1002/art.24149] [Cited by in Crossref: 127] [Cited by in F6Publishing: 100] [Article Influence: 10.6] [Reference Citation Analysis]
105 Ginsberg S, Rosner I, Slobodin G, Rozenbaum M, Kaly L, Jiries N, Boulman N, Awisat A, Hussein H, Novofastovski I, Silawy A, Rimar D. Infliximab for the treatment of refractory polyarteritis nodosa. Clin Rheumatol. 2019;38:2825-2833. [PMID: 30972576 DOI: 10.1007/s10067-019-04474-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
106 Franco DL, Ruff K, Mertz L, Lam-Himlin DM, Heigh R. Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol 2014;8:329-36. [PMID: 25473392 DOI: 10.1159/000369129] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
107 Anderson E, Gakhar N, Stull C, Caplan L. Gastrointestinal and Hepatic Disease in Vasculitis. Rheum Dis Clin North Am 2018;44:1-14. [PMID: 29149919 DOI: 10.1016/j.rdc.2017.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
108 Mahr AD. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one ‘anti-neutrophil cytoplasm antibodies-associated vasculitis’ entity? APMIS 2009;117:41-7. [DOI: 10.1111/j.1600-0463.2009.02476.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
109 Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol 2009;23:355-66. [PMID: 19508943 DOI: 10.1016/j.berh.2009.02.004] [Cited by in Crossref: 95] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
110 A. Adeyi O. Vascular and glomerular manifestations of viral hepatitis B and C: a review. Seminars in Diagnostic Pathology 2009;26:116-21. [DOI: 10.1053/j.semdp.2009.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Wieczorek S, Holle JU, Müller S, Fricke H, Gross WL, Epplen JT. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med (Berl) 2010;88:413-21. [PMID: 20049410 DOI: 10.1007/s00109-009-0580-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
112 Laudien M, Ambrosch P, Till A, Podschun R, Lamprecht P. [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement]. Z Rheumatol 2008;67:397-406. [PMID: 18600330 DOI: 10.1007/s00393-008-0324-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
113 Willcocks LC, Lyons PA, Rees AJ, Smith KG. The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther 2010;12:202. [PMID: 20236493 DOI: 10.1186/ar2928] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
114 Wu Z, Wu Q, Xu J, Chen S, Sun F, Li P, Bai Y, Zheng W, Chen H, Zhang F, Li Y. HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population. Int J Rheum Dis 2017;20:1009-15. [DOI: 10.1111/1756-185x.12561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
115 Tieu J, Lester S, Raymond W, Keen HI, Hill CL, Nossent J. Mortality and cause of death in patients with AAV/PAN in Australia-a population-based study. Rheumatology (Oxford) 2021:keab469. [PMID: 34117869 DOI: 10.1093/rheumatology/keab469] [Reference Citation Analysis]
116 De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, Martellucci S, de Vincentiis M. Polyarteritis nodosa: A contemporary overview. Autoimmun Rev. 2016;15:564-570. [PMID: 26884100 DOI: 10.1016/j.autrev.2016.02.015] [Cited by in Crossref: 100] [Cited by in F6Publishing: 69] [Article Influence: 20.0] [Reference Citation Analysis]
117 Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52:2926-35. [PMID: 16142760 DOI: 10.1002/art.21250] [Cited by in Crossref: 422] [Cited by in F6Publishing: 298] [Article Influence: 26.4] [Reference Citation Analysis]
118 Bosco L, Peroni A, Schena D, Colato C, Girolomoni G. Cutaneous manifestations of Churg-Strauss syndrome: report of two cases and review of the literature. Clin Rheumatol 2011;30:573-80. [PMID: 20949297 DOI: 10.1007/s10067-010-1593-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
119 Espinoza LR. Combination therapy to treat churg-strauss syndrome: corticosteroids with short- or long-term cyclophosphamide pulses. Curr Rheumatol Rep 2008;10:427-9. [PMID: 19007530 DOI: 10.1007/s11926-008-0069-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Holle JU, Moosig F, Dalhoff K, Gross WL. Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis Res Ther 2011;13:224. [PMID: 21722330 DOI: 10.1186/ar3307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
121 Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009;48:1560-5. [PMID: 19797309 DOI: 10.1093/rheumatology/kep304] [Cited by in Crossref: 159] [Cited by in F6Publishing: 128] [Article Influence: 13.3] [Reference Citation Analysis]
122 Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, Hausfater P, Roudier J, Bielefeld P, Petitjean P, Smadja D; French Vasculitis Study Group. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum. 2004;51:482-487. [PMID: 15188337 DOI: 10.1002/art.20401] [Cited by in Crossref: 97] [Cited by in F6Publishing: 68] [Article Influence: 5.7] [Reference Citation Analysis]
123 Mohammad AJ. An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford) 2020;59:iii42-50. [PMID: 32348522 DOI: 10.1093/rheumatology/keaa089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
124 Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33:197-207. [PMID: 19819109 DOI: 10.1016/j.jaut.2009.09.008] [Cited by in Crossref: 389] [Cited by in F6Publishing: 354] [Article Influence: 32.4] [Reference Citation Analysis]
125 Lai Q, Ma T, Li Z, Chang D, Zhao M, Chen M. Predictors for Mortality in Patients with Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis: A Study of 398 Chinese Patients. J Rheumatol 2014;41:1849-55. [DOI: 10.3899/jrheum.131426] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
126 Geetha D, Poulton CJ, Hu Y, Seo P, McGregor JA, Falk RJ, Hogan SL. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum 2014;43:778-83. [PMID: 24387818 DOI: 10.1016/j.semarthrit.2013.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
127 Kanecki K, Nitsch-Osuch A, Gorynski P, Tarka P, Tyszko P. Hospital Morbidity Database for Epidemiological Studies on Churg-Strauss Syndrome. Adv Exp Med Biol 2017;980:19-25. [PMID: 28255916 DOI: 10.1007/5584_2017_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
128 Liu S, Guo L, Zhang Z, Li M, Zeng X, Wang L, Liu Y, Zhang F. Cardiac manifestations of eosinophilic granulomatosis with polyangiitis from a single-center cohort in China: clinical features and associated factors. Ther Adv Chronic Dis 2021;12:2040622320987051. [PMID: 33613936 DOI: 10.1177/2040622320987051] [Reference Citation Analysis]
129 Cacoub P, Terrier B. Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am. 2009;35:125-137. [PMID: 19481001 DOI: 10.1016/j.rdc.2009.03.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
130 McCabe C, Jones Q, Nikolopoulou A, Wathen C, Luqmani R. Pulmonary-renal syndromes: an update for respiratory physicians. Respir Med 2011;105:1413-21. [PMID: 21684732 DOI: 10.1016/j.rmed.2011.05.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
131 Munera‐campos M, Bielsa I, Martínez‐morillo M, Aparicio G, Olivé A, Ferrándiz C. Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2020;18:1250-9. [DOI: 10.1111/ddg.14271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
132 Banerjee S, Grayson PC. Vasculitis Around the World: Epidemiologic Insights into Causality and a Need for Global Partnerships. J Rheumatol 2017;44:136-9. [PMID: 28148752 DOI: 10.3899/jrheum.161468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Jagiello P, Gross WL, Epplen JT. Complex genetics of Wegener granulomatosis. Autoimmunity Reviews 2005;4:42-7. [DOI: 10.1016/j.autrev.2004.06.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
134 Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ. Clinical Spectrum of Medium-Sized Vessel Vasculitis. Arthritis Care Res (Hoboken) 2017;69:884-91. [PMID: 27564269 DOI: 10.1002/acr.23007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
135 Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O, Sahin S, Barut K, Kasapcopur O. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int 2020;40:57-64. [PMID: 31352561 DOI: 10.1007/s00296-019-04391-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
136 Sauvetre G, Fares J, Caudron J, Dacher J, Girszyn N, Daragon A, Levesque H, Marie I. Intérêt de l’imagerie par résonance magnétique nucléaire au cours de l’atteinte cardiaque du syndrome de Churg-Strauss. Trois observations et revue de la littérature. La Revue de Médecine Interne 2010;31:600-5. [DOI: 10.1016/j.revmed.2010.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
137 Villiger PM, Guillevin L. Microscopic polyangiitis: Clinical presentation. Autoimmun Rev. 2010;9:812-819. [PMID: 20656070 DOI: 10.1016/j.autrev.2010.07.009] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
138 Just J, Bourgoin M, Amat F, Cottel N, Lambert N, Wanin S. Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab. ERJ Open Res 2020;6:00339-2020. [PMID: 33447610 DOI: 10.1183/23120541.00339-2020] [Reference Citation Analysis]
139 Fields JM, Dean AJ. Systemic causes of abdominal pain. Emerg Med Clin North Am 2011;29:195-210, vii. [PMID: 21515176 DOI: 10.1016/j.emc.2011.01.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
140 Gibson A, Stamp LK, Chapman PT, O'donnell JL. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology 2006;45:624-8. [DOI: 10.1093/rheumatology/kei259] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
141 de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW, Mahr AD, Niles JL, de Heer E, Bruijn JA, Bajema IM. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol 2008;3:237-52. [PMID: 18077783 DOI: 10.2215/CJN.03550807] [Cited by in Crossref: 67] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
142 Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 2015;30 Suppl 1:i14-22. [PMID: 25805746 DOI: 10.1093/ndt/gfv022] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 18.2] [Reference Citation Analysis]
143 Salvador F. ANCA associated vasculitis. Eur J Intern Med 2020;74:18-28. [PMID: 32005600 DOI: 10.1016/j.ejim.2020.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
144 Pagnoux C, Bienvenu B, Guillevin L. The spectrum of granulomatous vasculitides. Future Rheumatology 2006;1:729-50. [DOI: 10.2217/17460816.1.6.729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
145 Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, Epplen JT. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 2008;58:1839-48. [DOI: 10.1002/art.23496] [Cited by in Crossref: 77] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
146 Munera-Campos M, Bielsa I, Martínez-Morillo M, Aparicio G, Olivé A, Ferrándiz C. Manifestationen, Krankheitsverlauf und prognostische Parameter bei kutaner Polyarteriitis nodosa. J Dtsch Dermatol Ges 2020;18:1250-60. [PMID: 33251748 DOI: 10.1111/ddg.14271_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Tong X, Ma Y, Niu X, Yan Z, Liu S, Peng B, Peng S, Fan H. The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants. Medicine (Baltimore) 2016;95:e4325. [PMID: 27472712 DOI: 10.1097/MD.0000000000004325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
148 Pagnoux C, Guilpain P, Guillevin L. Polyangéite microscopique. La Presse Médicale 2007;36:895-901. [DOI: 10.1016/j.lpm.2007.01.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
149 Bala MM, Malecka-Massalska TJ, Koperny M, Zajac JF, Jarczewski JD, Szczeklik W. Anti-cytokine targeted therapies for ANCA-associated vasculitis. Cochrane Database Syst Rev 2020;9:CD008333. [PMID: 32990324 DOI: 10.1002/14651858.CD008333.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
150 Abbara S, Grateau G, Ducharme-Bénard S, Saadoun D, Georgin-Lavialle S. Association of Vasculitis and Familial Mediterranean Fever. Front Immunol 2019;10:763. [PMID: 31031761 DOI: 10.3389/fimmu.2019.00763] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
151 Mattsson G, Magnusson P. Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids. BMC Cardiovasc Disord 2017;17:299. [PMID: 29262787 DOI: 10.1186/s12872-017-0734-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Moiseev S, Novikov P, Mukhin N. HCV-associated cryoglobulinemia vasculitis: are its days numbered? Ann Rheum Dis 2017;76:e5. [PMID: 27797754 DOI: 10.1136/annrheumdis-2016-210636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Castelhano R, Win KM, Carty S. Celiac artery aneurysm causing an acute abdomen. BMJ Case Rep 2021;14:e240533. [PMID: 33883114 DOI: 10.1136/bcr-2020-240533] [Reference Citation Analysis]
154 Watts RA, Macgregor AJ, Mackie SL. HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis. Rheumatology 2015;54:359-62. [DOI: 10.1093/rheumatology/keu321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
155 MacDiarmid M, Nepogodiev D, Tiwari A, Duddy M, Carey M, Jobanputra P. Eosinophilic angiitis presenting with a true, fusiform, temporal artery aneurysm. Clin Case Rep 2017;5:769-73. [PMID: 28588807 DOI: 10.1002/ccr3.869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Iudici M, Pagnoux C, Courvoisier DS, Cohen P, Hamidou M, Aouba A, Lifermann F, Ruivard M, Aumaître O, Bonnotte B, Maurier F, Decaux O, Hachulla E, Karras A, Khouatra C, Jourde-Chiche N, Viallard JF, Blanchard-Delaunay C, Godmer P, Quellec AL, Quéméneur T, de Moreuil C, Régent A, Terrier B, Mouthon L, Guillevin L, Puéchal X; French Vasculitis Study Group. Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry. Semin Arthritis Rheum 2021;51:339-46. [PMID: 33601189 DOI: 10.1016/j.semarthrit.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Agard C, Rendu E, Leguern V, Ponge T, Masseau A, Barrier JH, Trochu JN, Hamidou MA, Guillevin L. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature. Semin Arthritis Rheum. 2007;36:386-391. [PMID: 17303217 DOI: 10.1016/j.semarthrit.2006.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
158 Younger DS. Epidemiology of Neurovasculitis. Neurologic Clinics 2016;34:887-917. [DOI: 10.1016/j.ncl.2016.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
159 Bensalem A, Mulleman D, Paintaud G, Azzopardi N, Gouilleux-Gruart V, Cornec D, Specks U, Ternant D. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. Clin Pharmacokinet 2020;59:519-30. [PMID: 31586310 DOI: 10.1007/s40262-019-00826-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Forbess L, Bannykh S. Polyarteritis Nodosa. Rheumatic Disease Clinics of North America 2015;41:33-46. [DOI: 10.1016/j.rdc.2014.09.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
161 Kimmoun A, Baux E, Das V, Terzi N, Talec P, Asfar P, Ehrmann S, Geri G, Grange S, Anguel N, Demoule A, Moreau AS, Azoulay E, Quenot JP, Boisramé-Helms J, Louis G, Sonneville R, Girerd N, Ducrocq N, Agrinier N, Wahl D, Puéchal X, Levy B. Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care 2016;20:27. [PMID: 26812945 DOI: 10.1186/s13054-016-1189-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
162 Weiner M, Bjørneklett R, Hrušková Z, Mackinnon B, Poulton CJ, Sindelar L, Mohammad AJ, Eriksson P, Gesualdo L, Geetha D, Crnogorac M, Jayne D, Hogan SL, Geddes C, Tesar V, Aasarød K, Segelmark M. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nephrol Dial Transplant 2019;34:301-8. [PMID: 29718465 DOI: 10.1093/ndt/gfy106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ganeshanandan LR, Brusch AM, Dyke JM, McLean-Tooke APC. Polyarteritis nodosa isolated to muscles-A case series with a review of the literature. Semin Arthritis Rheum 2020;50:503-8. [PMID: 31959304 DOI: 10.1016/j.semarthrit.2019.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Sato S, Migita K. Gastrointestinal Involvement of Systemic Vasculitis. In: Ohira H, Migita K, editors. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Singapore: Springer; 2019. pp. 137-53. [DOI: 10.1007/978-981-13-6524-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Herlyn K, Buckert F, Gross WL, Reinhold-keller E. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology 2014;53:882-9. [DOI: 10.1093/rheumatology/ket440] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
166 Befort P, Corne P, Filleron T, Jung B, Bengler C, Jonquet O, Klouche K. Prognosis and ICU outcome of systemic vasculitis. BMC Anesthesiol 2013;13:27. [PMID: 24083831 DOI: 10.1186/1471-2253-13-27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
167 Scott DGI, Watts RA. Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol 2013;17:607-10. [PMID: 23843034 DOI: 10.1007/s10157-013-0830-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
168 Trépo C, Amiri M, Guillevin L. Extrahepatic Manifestations of Hepatitis B Infection. In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 154-62. [DOI: 10.1002/9781118637272.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
169 Kim SM, Choi SY, Kim SY, Kim J. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Rheumatol Int 2019;39:1919-26. [PMID: 31552433 DOI: 10.1007/s00296-019-04447-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
170 Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol 2016;68:2945-52. [PMID: 27428559 DOI: 10.1002/art.39812] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 11.0] [Reference Citation Analysis]
171 Berti A, Cornec D, Crowson CS, Specks U, Matteson EL. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study. Arthritis Rheumatol 2017;69:2338-50. [PMID: 28881446 DOI: 10.1002/art.40313] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 13.8] [Reference Citation Analysis]
172 Renaudineau Y, Le Meur Y. Renal involvement in Wegener's granulomatosis. Clin Rev Allergy Immunol 2008;35:22-9. [PMID: 18172777 DOI: 10.1007/s12016-007-8066-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
173 Detoraki A, Tremante E, Poto R, Morelli E, Quaremba G, Granata F, Romano A, Mormile I, Rossi FW, de Paulis A, Spadaro G. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series. Respir Res 2021;22:185. [PMID: 34162391 DOI: 10.1186/s12931-021-01775-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Piram M, Maldini C, Mahr A. Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Current Opinion in Rheumatology 2012;24:193-200. [DOI: 10.1097/bor.0b013e32835059e5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
175 Vazquez-Romo KA, Rodriguez-Hernandez A, Paczka JA, Nuño-Suarez MA, Rocha-Muñoz AD, Zavala-Cerna MG. Optic Neuropathy Secondary to Polyarteritis Nodosa, Case Report, and Diagnostic Challenges. Front Neurol 2017;8:490. [PMID: 28979236 DOI: 10.3389/fneur.2017.00490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
176 Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 2005;7:270-5. [PMID: 16045829 DOI: 10.1007/s11926-005-0036-5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
177 Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 2008;38:816-23. [PMID: 18771432 DOI: 10.1111/j.1445-5994.2008.01672.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 4.8] [Reference Citation Analysis]
178 Rani L, Minz RW, Sharma A, Anand S, Gupta D, Panda N, Sakhuja V. Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis. Cytokine 2015;71:261-7. [DOI: 10.1016/j.cyto.2014.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
179 Narula N, Narula T, Derbes S, Espinoza LR. Churg-Strauss angiitis. Am J Med Sci 2014;348:522-7. [PMID: 24172234 DOI: 10.1097/MAJ.0b013e31829f8306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
180 Alotaibi A, Schneider SW. Eosinophilic Granulomatosis with Polyangiitis Manifesting as Recurrent Nasal Polyps and Hemorrhagic Necrotic Bullae: A Rare Disease Successfully Treated with Azathioprine. Case Rep Dermatol 2019;11:28-35. [PMID: 31043937 DOI: 10.1159/000497052] [Reference Citation Analysis]
181 Hiraike Y, Kodaira M, Sano M, Terazawa Y, Yamagata S, Terada S, Ohura M, Kuriki K. Polyarteritis nodosa diagnosed by surgically resected jejunal necrosis following acute abdomen. World J Gastroenterol 2013; 19(18): 2830-2834 [PMID: 23687422 DOI: 10.3748/wjg.v19.i18.2830] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
182 Spriewald BM, Witzke O, Wassmuth R, Wenzel RR, Arnold ML, Philipp T, Kalden JR. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis. 2005;64:457-461. [PMID: 15708894 DOI: 10.1136/ard.2004.025809] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
183 Miłkowska-dymanowska J, Laskowska P, Rzuczkowski M, Białas AJ, Piotrowski WJ, Górski P. Untypical Manifestations of Granulomatosis with Polyangiitis—A Review of the Literature. SN Compr Clin Med 2019;1:616-26. [DOI: 10.1007/s42399-019-00083-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
184 Chiu HF, Chen HC, Lu KC, Shu KH; Taiwan Society of Nephrology. Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology. BMC Nephrol 2018;19:6. [PMID: 29320993 DOI: 10.1186/s12882-017-0810-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
185 Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014;48-49:84-89. [PMID: 24485157 DOI: 10.1016/j.jaut.2014.01.029] [Cited by in Crossref: 119] [Cited by in F6Publishing: 73] [Article Influence: 17.0] [Reference Citation Analysis]
186 Carlson JA, Ng BT, Chen K. Cutaneous Vasculitis Update: Diagnostic Criteria, Classification, Epidemiology, Etiology, Pathogenesis, Evaluation and Prognosis: . The American Journal of Dermatopathology 2005;27:504-28. [DOI: 10.1097/01.dad.0000181109.54532.c5] [Cited by in Crossref: 142] [Cited by in F6Publishing: 97] [Article Influence: 8.9] [Reference Citation Analysis]
187 Howard T, Ahmad K, Swanson JA, Misra S. Polyarteritis nodosa. Tech Vasc Interv Radiol 2014;17:247-51. [PMID: 25770638 DOI: 10.1053/j.tvir.2014.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
188 Sreih AG, Mandhadi R, Aldaghlawi F, Khan A, Irshad V, Finn K, Block JA. ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity. Clin Rheumatol 2015;34:943-8. [PMID: 24752347 DOI: 10.1007/s10067-014-2617-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
189 Pierini FS, Scolnik M, Scaglioni V, Mollerach F, Soriano ER. Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study. Clin Rheumatol 2019;38:1935-40. [DOI: 10.1007/s10067-019-04463-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
190 Lhote F. [Churg-Strauss syndrome]. Presse Med 2007;36:875-89. [PMID: 17408916 DOI: 10.1016/j.lpm.2007.02.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
191 Ebert EC, Hagspiel KD, Nagar M, Schlesinger N. Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol. 2008;6:960-966. [PMID: 18585977 DOI: 10.1016/j.cgh.2008.04.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
192 Keogh KA. Leukotriene receptor antagonists and Churg-Strauss syndrome: cause, trigger or merely an association? Drug Saf 2007;30:837-43. [PMID: 17867722 DOI: 10.2165/00002018-200730100-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
193 Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 2015;26:545-53. [PMID: 25971154 DOI: 10.1016/j.ejim.2015.04.022] [Cited by in Crossref: 217] [Cited by in F6Publishing: 171] [Article Influence: 36.2] [Reference Citation Analysis]
194 Kanecki K, Nitsch-Osuch A, Gorynski P, Wierzba W, Tarka P, Tyszko P. Polyarteritis nodosa: decreasing incidence in Poland. Arch Med Sci 2019;15:1308-12. [PMID: 31572478 DOI: 10.5114/aoms.2017.68407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
195 Watts RA, Robson J. Introduction, epidemiology and classification of vasculitis. Best Practice & Research Clinical Rheumatology 2018;32:3-20. [DOI: 10.1016/j.berh.2018.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
196 Buonuomo PS, El Hachem M, Callea F, Bracaglia C, Diociaiuti A, Pardeo M, Campana A, Insalaco A, Cortis E, Ugazio AG. Necrosis of the tongue as first symptom of Polyarteritis Nodosa (PAN): unusual presentation of a rare disease in children. Rheumatol Int 2013;33:1071-3. [DOI: 10.1007/s00296-010-1642-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
197 Nakamoto K, Saraya T, Ogawa Y, Ishii H, Takizawa H. Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis. Respir Med 2018;139:101-5. [PMID: 29857992 DOI: 10.1016/j.rmed.2018.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
198 Guillemin F. Describing the epidemiology of rheumatic diseases: methodological aspects. Curr Opin Rheumatol. 2012;24:187-192. [PMID: 22227954 DOI: 10.1097/bor.0b013e32834ff314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
199 Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007;19:25-32. [PMID: 17143092 DOI: 10.1097/BOR.0b013e3280119854] [Cited by in Crossref: 151] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
200 Morgan MD, Savage CO. Vasculitis in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2005;19:215-233. [PMID: 15833689 DOI: 10.1016/j.bpg.2004.11.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
201 Guillevin L. Infections in vasculitis. Best Pract Res Clin Rheumatol 2013;27:19-31. [PMID: 23507054 DOI: 10.1016/j.berh.2013.01.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
202 Sharma RK, Lövström B, Gunnarsson I, Malmström V. Proteinase 3 Autoreactivity in Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis-Immunological versus clinical features. Scand J Immunol 2020;92:e12958. [PMID: 32794199 DOI: 10.1111/sji.12958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet PY, Brauner M, Kambouchner M, Huynh S, Naccache JM, Borie R, Piquet J, Mekinian A, Virally J, Uzunhan Y, Cadranel J, Crestani B, Fain O, Lhote F, Dhote R, Saidenberg-Kermanac'h N, Rosental PA, Valeyre D, Nunes H. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J 2017;50:1602419. [PMID: 28775045 DOI: 10.1183/13993003.02419-2016] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 19.8] [Reference Citation Analysis]
204 Pourafshar N, Sobel E, Segal M. A case of isolated renal involvement of polyarteritis nodosa successfully treated with steroid monotherapy. BMJ Case Rep 2016;2016:bcr2016215702. [PMID: 27440849 DOI: 10.1136/bcr-2016-215702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
205 Flint J, Morgan MD, Savage CO. Pathogenesis of ANCA-associated vasculitis. Rheum Dis Clin North Am 2010;36:463-77. [PMID: 20688244 DOI: 10.1016/j.rdc.2010.05.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
206 Segelmark M, Selga D. The challenge of managing patients with polyarteritis nodosa. Current Opinion in Rheumatology 2007;19:33-8. [DOI: 10.1097/bor.0b013e328011cb6f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
207 Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y, Jennette CE, Berg EA, Arnett FC Jr, Jennette JC, Falk RJ, Preston GA. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 2011;22:1161-7. [PMID: 21617122 DOI: 10.1681/ASN.2010101058] [Cited by in Crossref: 76] [Cited by in F6Publishing: 26] [Article Influence: 7.6] [Reference Citation Analysis]
208 Henegar C, Pagnoux C, Puéchal X, Zucker JD, Bar-Hen A, Le Guern V, Saba M, Bagnères D, Meyer O, Guillevin L; French Vasculitis Study Group. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008;58:1528-38. [PMID: 18438816 DOI: 10.1002/art.23470] [Cited by in Crossref: 69] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
209 Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, Parker JV, Vinoya AC, Uchida A, Acharya NR. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol 2013;156:752-8. [PMID: 23891336 DOI: 10.1016/j.ajo.2013.05.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
210 Shah AS, Amarapurkar DN. Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38:23-32. [PMID: 28627094 DOI: 10.1111/liv.13498] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
211 Pipitone N, Salvarani C. The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol 2008;22:897-911. [PMID: 19028370 DOI: 10.1016/j.berh.2008.09.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
212 Younger DS. Epidemiology of the Vasculitides. Neurologic Clinics 2019;37:201-17. [DOI: 10.1016/j.ncl.2019.01.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
213 Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken) 2014;66:454-63. [PMID: 23983119 DOI: 10.1002/acr.22115] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
214 Xiao H, Ciavatta D, Aylor DL, Hu P, de Villena FP, Falk RJ, Jennette JC. Genetically determined severity of anti-myeloperoxidase glomerulonephritis. Am J Pathol 2013;182:1219-26. [PMID: 23384999 DOI: 10.1016/j.ajpath.2012.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
215 Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol 2009;123:1226-36. [PMID: 19501230 DOI: 10.1016/j.jaci.2009.04.024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
216 Detoraki A, Di Capua L, Varricchi G, Genovese A, Marone G, Spadaro G. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study. J Asthma 2016;53:201-6. [PMID: 26377630 DOI: 10.3109/02770903.2015.1081700] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
217 Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, Polimeni A, de Vincentiis M. Pathophysiology and therapy of systemic vasculitides. EXCLI J 2020;19:817-54. [PMID: 32665772 DOI: 10.17179/excli2020-1512] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
218 Oyoo O, Espinoza LR. Infection-related vasculitis. Curr Rheumatol Rep 2005;7:281-7. [PMID: 16045831 DOI: 10.1007/s11926-005-0038-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
219 Kim DS, Shin D, Kim TG, Kim SH, Kim DY, Kim SM, Lee MG. Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis. Rheumatol Int 2015;35:719-25. [PMID: 25284376 DOI: 10.1007/s00296-014-3144-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
220 Neves PDMM, Mota LB, Dias CB, Yu L, Woronik V, Cavalcante LB, Malheiros DMAC, Jorge LB. Methimazole-Induced ANCA Vasculitis: A Case Report. Diagnostics (Basel) 2021;11:1580. [PMID: 34573922 DOI: 10.3390/diagnostics11091580] [Reference Citation Analysis]
221 Martin-Latry K, Bégaud B. Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 2010;19:256-65. [PMID: 20128015 DOI: 10.1002/pds.1912] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 9.0] [Reference Citation Analysis]
222 Collins CE, Quismorio FP Jr. Pulmonary involvement in microscopic polyangiitis. Curr Opin Pulm Med 2005;11:447-51. [PMID: 16093820 DOI: 10.1097/01.mcp.0000170520.63874.fb] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
223 Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol. 2005;19:191-207. [PMID: 15857791 DOI: 10.1016/j.berh.2004.11.006] [Cited by in Crossref: 91] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
224 Moazzam AA, Savvas SN, Amar AP, Ham SW, Panush RS, Clavijo LC. Diffuse aneurysmal disease – A review. Reviews in Vascular Medicine 2014;2:48-57. [DOI: 10.1016/j.rvm.2013.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
225 Sharma A, Sharma K. Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis. J Clin Exp Hepatol. 2013;3:204-212. [PMID: 25755502 DOI: 10.1016/j.jceh.2013.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
226 Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest 2009;136:507-18. [PMID: 19411292 DOI: 10.1378/chest.08-2990] [Cited by in Crossref: 89] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
227 Zampella JG, Vakili S, Doig S, Girardi N, Kwatra SG, Seo P, Patel M. Macular lymphocytic arteritis: Clinical-pathologic correlation of a rare vasculitis. JAAD Case Rep 2017;3:116-20. [PMID: 28337473 DOI: 10.1016/j.jdcr.2017.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Abe Y, Tada K, Yamaji K, Takasaki Y, Tamura N. Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa. Mod Rheumatol 2018;28:308-12. [PMID: 28648103 DOI: 10.1080/14397595.2017.1337265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
229 Pakrou N, Selva D, Leibovitch I. Wegener’s Granulomatosis: Ophthalmic Manifestations and Management. Seminars in Arthritis and Rheumatism 2006;35:284-92. [DOI: 10.1016/j.semarthrit.2005.12.003] [Cited by in Crossref: 117] [Cited by in F6Publishing: 75] [Article Influence: 7.8] [Reference Citation Analysis]
230 Ly KH, Guillevin L, Mouthon L. [Late-onset asthma in a traveler]. Presse Med 2011;40:1092-5. [PMID: 21964040 DOI: 10.1016/j.lpm.2011.07.015] [Reference Citation Analysis]